CRC 001

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension. We are doing this study to learn more about an investigational drug called Baxdrostat for treating high blood pressure that is not responding well enough to current treatment.

We are doing this study to learn more about an investigational drug called Baxdrostat for treating high blood pressure that is not responding well enough to current treatment. Hypertension is a serious condition that can cause several complications and may reduce your life expectancy if not treated appropriately. Baxdrostat has already been tested in participants with difficult-to-control high blood pressure in earlier research called “Phase 2” studies. Based on what we have learned in those studies about the potential for Baxdrostat to improve blood pressure levels, this Phase 3 study has been developed.